US SB2756

Caps patient cost-sharing for inhaler products at $15 per 30-day supply and eliminates deductibles for these products across private insurance, Medicare Part B, and Medicare Part D, effective January 1, 2026

Covers all maintenance, reliever, and rescue inhalation drugs for asthma and COPD, including metered dose inhalers, dry powder inhalers, nebulizers, bronchodilators, corticosteroids, and related equipment such as masks, tubing, and spacers

Amends the Public Health Service Act, Internal Revenue Code, and ERISA to apply cost-sharing limits to group health plans, individual health insurance, and employer-sponsored coverage

Creates a payment program for uninsured individuals where registered providers can bill the Secretary of HHS for inhaler products, with patients paying no more than $15 per month's supply

Provides safe harbors so high-deductible health plans (HDHPs) and catastrophic plans remain compliant when waiving deductibles for specified inhaler products